AstraZeneca today announced that the U.S. Food and Drug Administration (FDA) has approved SEROQUEL® (quetiapine fumarate) for the treatment of patients with depressive episodes associated with bipolar disorder. SEROQUEL already is approved for the treatment of acute manic episodes associated with bipolar...
FDA Approves AstraZeneca’s Seroquel® For Bipolar Depression Treatment
Survey Rates Hospital Safety, NEJM Examines Trend To Seek Medical Care Abroad
* “Leapfrog Hospital Quality and Safety Survey,” The Leapfrog Group: The survey evaluated 1,200 hospitals nationwide to determine the state of health care quality and safety in U.S. hospitals. Using the survey results, Leapfrog named 59 participating hospitals to the first Leapfrog Top Hospitals...
Computer Factory Workers At Increased Risk Of Cancer, Large Study Shows
Workers at computer factories are at increased risk of dying of cancer. The largest study of its kind published 18 Oct. 2006 in the open access journal Environmental Health (http://www.ehjournal.net/ looks at over 30,000 deaths of workers who had been employed at IBM factories in the USA. The study reveals...
Humira® Induced Clinical Remission In Patients With Crohn’s Disease Who Lost Response To, Or Were Intolerant To, Remicade®
Abbott today announced results from a study showing HUMIRA® (adalimumab) induced significantly higher rates of clinical remission compared to placebo in patients with moderately to severely active Crohn’s disease who lost response to, or were intolerant to, infliximab therapy. The data is being...
CIMZIATM (Certolizumab Pegol) Maintained Response And Remission In Crohn’s Patients Previously Treated With Infliximab
New data from a post hoc analysis of the PRECiSE clinical trial program demonstrated that the anti-TNF CIMZIATM (certolizumab pegol) maintained response and remission in patients with moderate to severe Crohn’s disease, regardless of whether or not they had been previously treated with infliximab....
Cancer Survivors Recognized For Helping Philadelphia-Area Patients
The American Society for Therapeutic Radiology and Oncology (ASTRO) has named Rita Davis-Goldsberry of Newark, Del., as the 2006 Survivor Circle Award Winner and Barbara Knight-Meyers, Ph.D., as the 2006 Distinguished Honoree. Ms. Davis-Goldsberry will be presented with her award and a $1,000 cash prize...
Consumers, Caregivers Taking Steps To Safer Surgery
Leading consumer advocacy groups have joined with the Surgical Care Improvement Project (SCIP) to improve patient safety during surgery and increase communication between patients and their caregivers. Of the 40 million inpatient and outpatient surgeries patients undergo each year, tens of thousands...
Cypher® Sirolimus-Eluting Coronary Stent Outperformed Taxus Stent In Long Coronary Lesions, New Trial
Results from a multicenter, prospective, randomized clinical trial indicate that the CYPHER® Stent performed better than the Taxus Stent in procedures involving long coronary lesions, which are considered some of the most complex blockages to treat with balloon angioplasty. The final results from the...
National Kidney Foundation Distributes Unique Survivor’s Kit For Katrina Survivors
The devastation unleashed by Hurricane Katrina caused the death of nearly 2,000 people in the Gulf area, and reminders of the disaster are widespread. For survivors of the storm, the mental and emotional costs continue to exact a toll. Now the National Kidney Foundation (NKF) is reaching out to a special...
Public Citizen Ranks State Online Physician Directories
New Jersey ranks first in the nation for providing the best information on its doctors through the Internet, according to a study released Wednesday by consumer advocacy group Public Citizen, the New York Times reports. For the study, Public Citizen examined states’ physician licensing board Web...